Bowen DM - Search Results

1

Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.

Francis PT, Sims NR, Procter AW, Bowen DM. Francis PT, et al. Among authors: bowen dm. J Neurochem. 1993 May;60(5):1589-604. doi: 10.1111/j.1471-4159.1993.tb13381.x. J Neurochem. 1993. PMID: 8473885 Review. No abstract available.

2

Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.

Procter AW, Wong EH, Stratmann GC, Lowe SL, Bowen DM. Procter AW, et al. Among authors: bowen dm. J Neurochem. 1989 Sep;53(3):698-704. doi: 10.1111/j.1471-4159.1989.tb11760.x. J Neurochem. 1989. PMID: 2569500

3

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM. Procter AW, et al. Among authors: bowen dm. J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x. J Neurochem. 1988. PMID: 3339353

4

Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease.

Dijk SN, Francis PT, Stratmann GC, Bowen DM. Dijk SN, et al. Among authors: bowen dm. J Neurochem. 1995 Nov;65(5):2165-9. doi: 10.1046/j.1471-4159.1995.65052165.x. J Neurochem. 1995. PMID: 7595503

5

Neurotransmitters and second messengers in aging and Alzheimer's disease.

Francis PT, Webster MT, Chessell IP, Holmes C, Stratmann GC, Procter AW, Cross AJ, Green AR, Bowen DM. Francis PT, et al. Among authors: bowen dm. Ann N Y Acad Sci. 1993 Sep 24;695:19-26. doi: 10.1111/j.1749-6632.1993.tb23021.x. Ann N Y Acad Sci. 1993. PMID: 7902054 Review.

6

Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication.

Chen CP, Alder JT, Bowen DM, Esiri MM, McDonald B, Hope T, Jobst KA, Francis PT. Chen CP, et al. Among authors: bowen dm. J Neurochem. 1996 Apr;66(4):1592-8. doi: 10.1046/j.1471-4159.1996.66041592.x. J Neurochem. 1996. PMID: 8627315

7

Neuronal pathology in relation to molecular biology and treatment of Alzheimer's disease.

Francis PT, Bowen DM. Francis PT, et al. Among authors: bowen dm. Mol Cell Biol Hum Dis Ser. 1994;4:25-54. doi: 10.1007/978-94-011-0709-9_2. Mol Cell Biol Hum Dis Ser. 1994. PMID: 9439743 Review. No abstract available.

8

A glycine site as therapeutic target.

Francis PT, Procter AW, Bowen DM. Francis PT, et al. Among authors: bowen dm. Ann N Y Acad Sci. 1991;640:184-8. doi: 10.1111/j.1749-6632.1991.tb00214.x. Ann N Y Acad Sci. 1991. PMID: 1663714 Review. No abstract available.

9

Characterisation of the glycine modulatory site of the N-methyl-D-aspartate receptor-ionophore complex in human brain.

Procter AW, Stratmann GC, Francis PT, Lowe SL, Bertolucci PH, Bowen DM. Procter AW, et al. Among authors: bowen dm. J Neurochem. 1991 Jan;56(1):299-310. doi: 10.1111/j.1471-4159.1991.tb02596.x. J Neurochem. 1991. PMID: 1670955

10

Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

Palmer AM, Francis PT, Benton JS, Sims NR, Mann DM, Neary D, Snowden JS, Bowen DM. Palmer AM, et al. Among authors: bowen dm. J Neurochem. 1987 Jan;48(1):8-15. doi: 10.1111/j.1471-4159.1987.tb13120.x. J Neurochem. 1987. PMID: 2432177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page